SC 13G Filing

Company

Aurinia Pharmaceuticals Inc.

Filed

October 28, 2022

Accession Number

0001172661-22-002260

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →